The vaccine against COVID-19 for infants and toddlers has taken another step closer after Australian regulators confirmed they are estimating a low dose of Spikevax from Moderna.
There are currently no vaccines against COVID-19 approved for children under the age of four, children under the age of five are given a Pfizer injection.
Spikevax is available for children over the age of six, and Moderna Australia has approached the Therapeutic Products Administration to distribute it to young children.
On Friday, the TGA confirmed that it was conducting an evaluation using a low-dose Spikevax, 25 micrograms in 0.25 ml, for children aged six months to five years.
This is less than 50 micrograms in 0.25 ml, which is currently used for children aged 6 to 11 years.
Spikevax, an mRNA vaccine, uses the genetic code to ensure the production of coronavirus thorn protein.
Immune cells then recognize the adhesion protein as foreign and begin to build an immune response against it.
https://thewest.com.au/news/coronavirus/tga-evaluates-baby-covid-19-vaccine-c-6792264
